“Efficacy of daclatasvir plus peginterferon alfa and ribavirin for patients with chronic hepatitis C genotype 4 infection” (2017) Bangladesh Journal of Pharmacology, 12(1), pp. 12–22. doi:10.3329/bjp.v12i1.29940.